BiotechTube
Home/Cognition Therapeutics/Jeffrey M. Dayno
JM

Jeffrey M. Dayno

Director

Cognition Therapeutics

Therapeutic Areas

Alzheimer's DiseaseDementia with Lewy BodiesNeuro-ophthalmology

Cognition Therapeutics Pipeline

DrugIndicationPhase
CT1812Mild-to-Moderate Alzheimer's DiseasePhase 2

Leadership Team at Cognition Therapeutics

LR
Lisa Ricciardi
President and Chief Executive Officer
AC
Anthony Caggiano
Chief Medical Officer
KI
Kenneth I. Moch
Chairman of the Board
View full Cognition Therapeutics profile